Treatment of Bone Marrow Failure, Post Allogeneic Bone Marrow Transplant,w ith CD34+ Cell-Enriched Hematopoietic Stem Cell Infusion (Miltenyi Biotec's CliniMACS CD34 Reagent System) A HDE Treatment Protocol

  • Enrollment

    This study is not currently enrolling.

  • Associated Conditions

  • Research Area

    Cancer Research

  • Principal Investigator

    Juan Varela

  • Sponsor

    AdventHealth CFD

[Shell Only] - HUD/CUD.